Co-designed strategies for delivery of positive newborn bloodspot screening results to parents: the ReSPoND mixed-methods study

Author:

Chudleigh Jane1ORCID,Holder Pru2ORCID,Fusco Francesco3ORCID,Bonham James R4ORCID,Bryon Mandy5ORCID,Moody Louise6ORCID,Morris Stephen3ORCID,Olander Ellinor K2ORCID,Simpson Alan7ORCID,Chinnery Holly8ORCID,Ulph Fiona9ORCID,Southern Kevin W10ORCID

Affiliation:

1. Cicely Saunders Institute, King’s College London, London, UK

2. Centre for Maternal and Child Health Research, City, University of London, London, UK

3. School of Clinical Medicine, University of Cambridge, Cambridge, UK

4. Division of Pharmacy, Diagnostics and Genetics, Sheffield Children’s NHS Foundation Trust, Sheffield, UK

5. Paediatric Psychology and Play Services, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK

6. School of Art and Design, Coventry University, Coventry, UK

7. Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King’s College London, London, UK

8. Faculty of Sports, Health and Applied Science, St Mary’s University Twickenham, London, UK

9. Division of Psychology and Mental Health, University of Manchester, Manchester, UK

10. Women’s and Children’s Health, University of Liverpool, Liverpool, UK

Abstract

Background Newborn bloodspot screening identifies presymptomatic babies who are affected by genetic or congenital conditions. Each year, around 10,000 parents of babies born in England are given a positive newborn bloodspot screening result for one of nine conditions that are currently screened for. Despite national guidance, variation exists regarding the approaches used to communicate these results to families; poor communication practices can lead to various negative sequelae. Objectives Identify and quantify approaches that are currently used to deliver positive newborn bloodspot screening results to parents (phase 1). Develop (phase 2), implement and evaluate (phase 3) co-designed interventions for improving the delivery of positive newborn bloodspot screening results. Quantify the resources required to deliver the co-designed interventions in selected case-study sites and compare these with costs associated with current practice (phase 3). Design This was a mixed-methods study using four phases, with defined outputs underpinned by Family Systems Theory. Setting All newborn bloodspot screening laboratories in England (n = 13). Participants Laboratory staff and clinicians involved in processing or communicating positive newborn bloodspot screening results, and parents of infants who had received a positive or negative newborn bloodspot screening result. Interventions Three co-designed interventions that were developed during phase 2 and implemented during phase 3 of the study. Main outcome measure Acceptability of the co-designed interventions for the communication of positive newborn bloodspot screening results. Results Staff were acutely aware of the significance of a positive newborn bloodspot screening result and the impact that this could have on families. Challenges existed when communicating results from laboratories to relevant clinicians, particularly in the case of congenital hypothyroidism. Clinicians who were involved in the communication of positive newborn bloodspot screening results were committed to making sure that the message, although distressing for parents, was communicated well. Despite this, variation in communication practices existed. This was influenced by many factors, including the available resources and lack of clear guidance. Although generally well received, implementation of the co-designed interventions in practice served to illuminate barriers to acceptability and feasibility. The interventions would not influence NHS expenditure and could be cost neutral when delivered by teleconsultations. Limitations Participants with a pre-existing interest in this topic may have been more likely to self-select into the study. The researchers are experienced in this field, which may have biased data collection and analysis. COVID-19 hindered implementation and related data collection of the co-designed interventions. Conclusions There was variation in the processes used to report positive newborn bloodspot screening results from newborn bloodspot screening laboratories to clinical teams and then to families. The various practices identified may reflect local needs, but more often reflected local resource. A more consistent ‘best practice’ approach is required, not just in the UK but perhaps globally. The co-designed interventions represent a starting point for achieving this. Future work Future work should include a national evaluation study with predefined outcomes, accompanied by an economic evaluation, to assess the acceptability, feasibility and usability of the co-designed interventions in practice nationally. Trial registration This trial is registered as ISRCTN15330120. Funding This project was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme and will be published in full in Health and Social Care Delivery Research; Vol. 10, No. 19. See the NIHR Journals Library website for further project information.

Funder

Health and Social Care Delivery Research (HSDR) Programme

Publisher

National Institute for Health and Care Research (NIHR)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3